
|Articles|January 26, 2004
Cover Story -- COLORECTAL CANCER: NO LONGER AN UNSPEAKABLE SUBJECT
As two new drugs await FDA approval, R.Ph.s can urge patients to get screened for this common malignancy
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Lower Baseline BMI Predicts Weight Loss At 6 Months With Liraglutide
2
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
3
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
4
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
5


























































































































































